Screener
Monte Rosa Therapeutics, Inc. GLUE Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Monte Rosa Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
FAQ
- What is Monte Rosa Therapeutics, Inc.'s free cash flow margin?
- Monte Rosa Therapeutics, Inc. (GLUE) reported free cash flow margin of -111.7% in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s free cash flow margin changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s free cash flow margin decreased by 933.3% year-over-year, from 13.4% to -111.7%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Monte Rosa Therapeutics, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude